Biotech Week
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Biotech Week
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Angiology
Long-term survival after coronary artery bypass graft surgery is assessed
October 25th, 2006
Long-term survival of patients after coronary artery bypass graft surgery shows no difference between the pre-stent and post-stent eras. According to a study from the United States, "Although coronary artery bypass graft surgery (CABG) has long been the 'gold standard' for treatment of multivessel coronary artery disease, current percutaneous interventional technologies are challenging that claim. We sought to determine long-term survival after isolated CABG to establish a baseline for comparison with interventional patients." "From 1968 through 2003, 20,835 patients underwent 22,378 isolated CABG procedures by a single surgical team. The...
Source: Biotech Week (2006-10-25)
|
